CCDC170 Antikörper (Coiled-Coil Domain Containing 170) (Cy5)

Details for Product anti-CCDC170 Antibody No. ABIN1705103
Antigen
  • C6orf97
  • bA282P11.1
  • RGD1310945
  • coiled-coil domain containing 170
  • CCDC170
  • Ccdc170
Reaktivität
Human, Maus, Ratte (Rattus)
29
14
14
Wirt
Kaninchen
29
Klonalität
Polyklonal
Konjugat
Dieser CCDC170 Antikörper ist konjugiert mit Cy5
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
18
12
6
6
4
3
1
1
1
1
1
Optionen
Immunogen KLH conjugated synthetic peptide derived from human C6orf97
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere CCDC170 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung C6orf97 (CCDC170 Antibody Abstract)
Hintergrund

Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf97 gene product has been provisionally designated C6orf97 pending further characterization.

Synonyms: bA282P11.1, C6orf97, CC170_HUMAN, Chromosome 6 open reading frame 97, Coiled coil domain containing protein C6orf97, Coiled-coil domain-containing protein C6orf97, FLJ23305, Hypothetical protein LOC80129, LOC80129.

Gen-ID 80129
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?